In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

• Kentaro Minagawa,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Muhammad O. Jamil,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Mustafa AL-Obaidi,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Larisa Pereboeva,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Donna Salzman,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Harry P. Erba,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Lawrence S. Lamb,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Ravi Bhatia,

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Shin Mineishi,

  Current address: Hematology/Oncology, Penn State Hershey Medical Center, Hershey, PA, United States of America

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Antonio Di Stasi

  * E-mail: adistasi@uabmc.edu

  Affiliation Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America

  http://orcid.org/0000-0002-7886-3514

  ⨯